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Abstract
Background: Tic disorders have commonly occurring and well recognized comorbidities including obsessive-compulsive disorder (OCD) and attention deficit
hyperactivity disorder (ADHD). Shorter stature is not generally appreciated as an associated feature.
Methods: Case reports and a literature review.
Results: We describe four recently encountered patients with tics and shorter stature. The literature suggests that in addition to OCD and ADHD, shorter stature
may also commonly accompany tic disorders. A variety of neuroendocrine mechanisms have been proposed.
Discussion: The potential associations between shorter stature and tic disorders and the common comorbidities OCD and ADHD deserve more attention. More
research is needed to establish the strength of these associations and the underlying neurobiological mechanisms.
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Introduction
Tourette syndrome (TS) is a childhood-onset condition character-
ized by chronic motor and vocal tics. A number of comorbidities have
been established to commonly accompany TS, including obsessive-
compulsive disorder (OCD) and attention deficit hyperactivity disorder
(ADHD).1 Tics can also be seen in other neurodevelopmental
conditions such as autism spectrum disorder (ASD).2 Since January
2014, we have evaluated 48 children referred for tics, and we
encountered 4 patients with tics and shorter stature, a condition not
generally associated with tics. We now present these cases and discuss
the literature regarding possible links between tics and shorter stature.
Case reports
Case 1. A 13-year-old female was born with the umbilical cord
wrapped around her neck, requiring an emergency cesarean section.
From birth, she had a small head circumference and an abnormal
growth curve, remaining in the 3rd to 4th percentile for length/height
and in the 5th to 9th percentile for weight. At the age of nine, she
developed motor tics including eyeblinking, eye rolling, facial move-
ments, platysma tightening, eyebrow raising, bruxism, and a throat-
clearing vocal tic. She reported some mental fogginess in school with
problems following directions and also some obsessiveness with certain
thoughts and images staying in her consciousness. The tics did not
respond to guanfacine, and although she experienced some relief with
topiramate 25 mg/day, this drug caused mental slowness and it was
stopped. The eyeblinking tics improved following local intramuscular
injections of botulinum toxin. One of the patient’s two older sisters has
short stature (below the 1st percentile) but no tics. The other sister’s
height is in the 45th percentile, the mother is in the 40th percentile, and
the father is in the 50th percentile. The patient has no other medical
problems, is mildly delayed in sexual development (Tanner staging,
treated with estrogen), has not been treated with any other
medications, has no known cause of shorter stature, and has a normal
nutrition and dietary history.
Case 2. This 14-year-old female experienced developmental delays
in physical, academic, emotional, impulse control, attention, and social
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areas. She was born with decreased muscle tone and had early
difficulty with visual tracking. She was diagnosed with a sensory
integration disorder (sensitivity to noises) in early childhood. She had
delayed social and emotional milestones. Ultimately, she was
diagnosed with ASD. Her growth curves were abnormal, with height
in the 19th percentile at the age of eight and the 1st percentile at age 14.
Her weight is currently in the 7th percentile. She had delayed
dentition, breast development, and puberty onset. At age 12 she was
found to have low thyroxine (3.6 mcg/dL) but has not received thyroid
replacement therapy. The patient first developed tics at age 3,
including fist clenching, foot tapping, and head shaking. Because the
tics caused impaired functioning and impacted her self-esteem, she was
treated with guanfacine 1 mg/day with limited improvement.
Risperidone up to 1.5 mg/day was added but was not tolerated and
offered no benefit. Aripiprazole 2.5 mg at bedtime has led to an
improvement in the tics. The patient’s mother and father are in the
36th and 45th percentiles for height, respectively. The patient has no
other medical problems, has taken no other medications on a chronic
basis, and has no known nutritional or dietary problems or other
known causes of shorter stature.
Case 3. This 14-year-old male first manifested tics around the age of
eight, including lip licking, eyeblinking, head jerking, and teeth
clicking. His length/height has remained in the 10–15th percentile. At
ages 11 and 14, his weight was in the 24th and 12th percentiles,
respectively. He is scheduled to have an endocrinological evaluation
for shorter stature. Both parents are in the 45th–55th percentiles for
height. The patient has not taken any medication on a chronic basis,
has no other health problems, no other known causes of shorter
stature, and no known nutritional or dietary problems.
Case 4. This 14-year-old male was diagnosed with ADHD in the 3rd
grade due to short attention span and distractibility. He has been
treated with guanfacine, clonidine (currently 0.3 mg/day), and
methylphenidate (currently 10 mg/9 hours transdermally). Around
the age of seven, he developed mild motor (eyeblinking, neck, facial)
and vocal (throat clearing) tics, as well as some mild obsessive-
compulsive features (perfectionism, evening up). His height and weight
were between the 10th and 25th percentiles for the first 10 years of life
but are currently at the 4th and 6th percentiles, respectively. His bone
age is estimated at age 12 years and 0 months, nearly two standard
deviations below his chronological age. He has been referred to an
endocrinologist for evaluation of short stature. The patient’s older
brother has TS, ADHD, and mild obsessive-compulsive symptoms, but
his height is in the 63rd percentile. The parents are in the 50th–55th
percentile for height. The patient has no other medical problems, has
not taken any other medications on a chronic basis, has no other
known causes of shorter stature, and no known nutritional or dietary
problems.
Discussion
Short stature is defined as height that is more than two standard
deviations below the mean for an individual’s age and sex or in the
bottom 3% of the population, and it affects approximately 2.3% of the
US population.3 Lesser degrees of low height are referred to as
‘‘shorter’’ stature. Short or shorter stature may be caused by growth
hormone failure, other endocrine disorders such as hypothyroidism, a
variety of chronic illnesses, or malnutrition.3 Short stature is also
commonly associated with certain genetic diseases, such as a homeo-
box SHOX gene mutation or Down syndrome.4
The four cases described here presented with tic disorders and
shorter stature. They exhibited some heterogeneity in that tics
occurred in the context of TS or ASD. In addition, potential
confounding factors that might contribute to shorter stature, including
perinatal problems, relatives with short or shorter stature, comorbid-
ities such as OCD and ADHD, and medication use, make it difficult to
establish a link between shorter stature and tics per se. There may be
an association between shorter stature and brain neurodevelopmental
disorders in general.
Few previous reports have linked tic disorders to shorter stature. A
review of the neurological manifestations of celiac disease mentioned
one case with chronic tics, ADHD, and short stature.5 A study in Israel
found that among 38 children with TS, 45% were in the lowest height
quartile.6 The authors speculated that brain neurotransmission
disturbances in TS may adversely affect neuroendocrine function,
resulting in reduced height. Indeed, the dopamine D2 receptors
thought to underlie a dopamine neurotransmission abnormality in TS
also play a role in growth hormone release.3 Allelic variations in the
D2 receptor gene have been identified in children with short stature.7
Disturbances of the endogenous opioid system have also been
suggested to occur in TS,8 and this system is known to interact with
the hypothalamic-pituitary axis and influence growth.9 Thus, any
association between tic disorders and reduced height may be related to
neurotransmitter and/or neuroendocrine disturbances.
One potential mechanism is suggested by certain genetic syndromes
characterized by a combination of tics and short stature. Deletions of
chromosome 22q11.2 have been associated with developmental delay
and ASD. Such deletions may result in reduced expression of the
catechol-O-methyltransferase (COMT) gene, which is involved in
metabolizing dopamine and other catecholamines.10 Low COMT
activity has been associated with tics and other hyperkinetic movement
disorders.11 Some patients with 22q11.2 deletions have exhibited
cervical and thoracic vertebrae fusion (Klippel-Feil anomaly) that can
contribute to short stature, but short stature has also been observed in
individuals with this syndrome without vertebral fusion.10
OCD is clinically and genetically associated with TS and is
considered along with ADHD to constitute the ‘‘TS triad.’’1 Thus, it
is notable that short stature has been reported to be common in
adolescent males, but not females, with OCD.12 Blunted nocturnal
growth hormone secretion, decreased pituitary gland volume, and
delayed onset of puberty have all been observed in OCD patients.12
Abnormal serotonin neurotransmission in the brain has been suggested
to occur in OCD, and some serotonin receptor subtypes (1D and 2C)
play a role in the neuroendocrine regulation of growth hormone.13
Because of the genetic link between OCD and TS, it is possible that
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these mechanisms may contribute to shorter stature in individuals with
tic disorders.
It is believed that long-term treatment of ADHD with stimulant
medications is associated with a small but significant reduction in
growth,14 and it has been suggested that the mechanism involves drug-
induced dopamine transporter blockade and resultant elevated
dopamine levels in the hypothalamus.15 Whether ADHD itself is
linked to growth reduction or delay is more controversial.14,16,17
Thus, several sources of evidence, although preliminary, indicate a
potential link between shorter stature and tics, as well as the associated
conditions OCD and ADHD. Our case series raises the possibility of
an association between tics and shorter stature but cannot provide
more than suggestive evidence given that it is not case-controlled and
there are potentially confounding clinical aspects for the four cases.
Further research is needed to establish the strength of the associations
and to clarify underlying neuroendocrine mechanisms.
References
1. Kurlan R. Tourette’s syndrome (Clinical Practice). New Engl J Med 2010;
363:2332–2338.
2. Ringman JM, Jankovic J. Occurrence of tics in Asperger’s syndrome and
autistic disorder. J Child Neurol 2000;15:394–400.
3. Cohen LE. Idiopathic short stature: A clinical review. JAMA 2014;311:
1787–1796.
4. Rappold GA, Fukami M, Niesler B, et al. Deletions of the homeobox gene
SHOX (short stature homeobox) are an important cause of growth failure in
children with short stature. J Clin Endocrinol Metab 2002;87:1402–1406.
5. Zelnik N, Pacht V, Obeid R, Lerner A. Range of neurological disorders in
patients with celiac disease. Pediatrics 2004;113:1672–1676.
6. Zelnik N, Newfield RS, Silman-Stolar Z, Goikhman I. Height distribution
in children with Tourette syndrome. J Child Neurol 2002;17:200–204.
7. Miyake H, Nagashima K, Onigata K, Takano Y, Morikawa A,
Nagashima T. Allelic variations of the D2 dopamine receptor gene in children
with idiopathic short stature. J Hum Genet 1999;44:26–29.
8. Gillman MA, Sandyk R. The endogenous opioid system in Gilles de la
Tourette syndrome. Med Hypotheses 1986;19:371–378.
9. Cicero T, Schainker B, Meyer E. Endogenous opioids participate in the
regulation of the hypothalamic-pituitary-luteinizing hormone axis and testos-
terone’s negative feedback control of luteinizing hormone. Endocrinol 1979;104:
1286–1291.
10. Clarke R, Zhi F, Diwan A, Gilbert D. Tourette syndrome and Klippel-
Feil anomaly in a child with chromosome 22q11 duplication. Case Reports Med
2009;361518.
11. Cavallini M, Bella D, Catalano M, Bellodi L. An association study
between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette’s
syndrome. Psychiatry 2000;97:93–100.
12. Hu Y, Wehrly R, Gorrindo T, et al. Gender specific short stature in male
adolescents with obsessive compulsive disorder. J Obs Compul Rel Dis 2013;2:30–
36.
13. Mota A, Bento A, Pen˜alva A, Pombo M, Dieguez C. Role of the
serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone
secretion. J Clin Endocrinol 1995;80:1973–1977.
14. Swanson JM, Elliott GR, Greenhill LL, et al. Effects of stimulant
medication on growth rates across 3 years in the MTA follow-up. J Am Acad
Child Adolesc Psychiatry 2007;46:1015–1027.
15. Caron M. Growth in the dopamine transporter knockout animal model
of ADHD. Neuropsychopharm 2004;29:S555–S562.
16. Spencer TJ, Biedernman J, Harding M, et al. Growth deficits in ADHD
children revisited: evidence for disorder-associated growth delays? J Am Acad
Child Adolesc Psychiatry 1996;35:1460–1469.
17. Farone SV, Lecendreux M, Konofal E. Growth dysregulation and
ADHD: an epidemiologic study of children in France. J Attention Dis 2012;16:
572–578.
Tics and Shorter Stature Holleb P, Rabin M, Kurlan R
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services3
